CH Biomedical's CH-VAD® on the Exhibition of the Great Achievements in Celebration of the 70th Anniversary of the Establishment of the People’s Republic of China

2019.09.24 25

 

On September 23, 2019, the grand exhibition of the great achievements in celebration of the 70th anniversary of the establishment of the People's Republic of China (PRC) opened at Beijing Exhibition Center. Chronologically, the exhibition comprehensively reviewed the glorious history and demonstrated the important scientific achievements of the People’s Republic of China in the past 70 years from 1949 to 2019. CH Biomedical’s CH-VAD®, the implantable left ventricular assist system was selected for the Exhibition as the only medical device, attracting much attention.

The CH-VAD implantable left ventricular assist system was developed by CH Biomedical independently with whole intellectual property rights. It is a miniaturized fully magnetically levitated VAD. It has provided a therapy that can significantly prolong life and improve the quality of life for patients with advanced heart failure. As a highly sophisticated medical device, VAD represents the scientific and technological level of a country's high-end medical device industry; and the LVAD system based on the full magnetic levitation technology represents the mainstream cutting-edge technology of VAD in the world currently. CH Biomedical focuses on research and development of a miniaturized fully magnetically levitated VAD, has completed its comprehensive system innovation, the device has reached the international leading level in blood compatibility, implant invasion, reliability, and other key performance indicators.

The exhibition of CH-VAD as a high-end medical device on the Exhibition of the great achievements in celebration of the 70th anniversary of the establishment of our country is a great honor to CH Biomedicalit is a recognition of the company's insistence on independent innovation of VAD. In the future, CH Biomedical will continue to carry out comprehensive and in-depth technology accumulation, through continuous research and development, and breakthroughs made in key technologies, therefore, to contribute to scientific and technological innovation of China's high-end medical device industry.

 

Hot
  • People's Daily Praises CH Biomedical for Surpassing International Technological Barriers and Benefiting Numerous Patients2023.08.07

    On August 7, People’s Daily published an article titled Domestic Fully Magnetically Levitated VAD Serving Patients, commending CH Biomedical for breaking the international technological monopoly for developing a domestically produced, fully magnetically levitated VAD with independent intellectual property rights. The device is currently available in nearly 40 hospitals across China, enabling over 140 patients with advanced heart failure to embark on a “new life”.

  • "CH-VAD Approval" Selected for Inclusion in China's Important Medical Advancements in 20212022.04.17

    Recently, at the 2022 China Medical Development Conference—widely regarded as the country’s premier medical forum—the Chinese Academy of Medical Sciences (CAMS) released two lists: China’s Major Medical Achievements of the 21st Century and China’s Important Medical Advancements in 2021. As a global innovator in the field of Ventricular Assist Devices (VADs), CH Biomedical’s independently developed CH-VAD (NMPA (A) 20213120987) was included in China’s Important Medical Advancements in 2021.

  • Dr. Chen and Dr. Lin Invited to Deliver a Plenary Speech at The 2019 Gordon Research Conference 2019.09.30

    From 9th to 14th of June 2019, the Gordon Research Conference was held in Barcelona, Spain. The conference theme this year was on Mechanical Circulatory Support (MCS) and brought together world-renowned doctors, scholars, and researchers in MCS field. Dr. Chen, CEO of the company, and Dr. Lin, CTO were invited to attend the conference and delivered a plenary speech.